Furthermore, STAT3 activation through JAK/STAT3 and Ras/Raf/MAPK has been reported in an in vitro study conducted on the K562 chronic myeloid leukemia (CML) cell line (Shi et al., 2018). This evidence concerns the gene STAT3 and chronic myelogenous leukemia, BCR-ABL1 positive.